|1.||Denmeade, Samuel R: 2 articles (04/2013 - 08/2007)|
|2.||Merchant, Rosemina: 2 articles (04/2013 - 08/2007)|
|3.||Mukhina, Galina L: 2 articles (08/2012 - 04/2009)|
|4.||Brodsky, Robert A: 2 articles (08/2012 - 04/2009)|
|5.||Hu, Rong: 2 articles (08/2012 - 04/2009)|
|6.||Varma, Neelam: 1 article (05/2015)|
|7.||Sachdeva, Man Updesh Singh: 1 article (05/2015)|
|8.||Varma, Subhash: 1 article (05/2015)|
|9.||Bose, Parveen: 1 article (05/2015)|
|10.||Chandra, Dinesh: 1 article (05/2015)|
|1.||Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
05/01/2015 - "In the last few years, proaerolysin conjugated with fluorescein (FLAER) has become an important component of antibody panel used for the detection of paroxysmal nocturnal hemoglobinuria (PNH) clone. "
11/15/2006 - "Units of analysis in accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH."
07/15/2005 - "Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH."
|2.||Prostatic Neoplasms (Prostate Cancer)
|3.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/01/2013 - "We conducted a safety and efficacy evaluation of intraprostatic injection of PRX302, a modified pore forming protein (proaerolysin) activated by prostate specific antigen, as a highly targeted, localized approach to treat lower urinary tract symptoms due to benign prostatic hyperplasia. "
|4.||Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/01/2012 - "We used peripheral blood flow cytometry to identify glycosylphosphatidylinositol-anchor deficient blood cells, a proaerolysin-resistant colony forming cell assay to select glycosylphosphatidylinositol-anchor deficient progenitor cells, a novel T-lymphocyte enrichment culture assay with proaerolysin selection to expand glycosylphosphatidylinositol-anchor deficient T lymphocytes, and PIG-A gene sequencing assays to identify and analyze PIG-A mutations in patients with aplastic anemia and myelodysplastic syndromes. "
|5.||Burkitt Lymphoma (Burkitt's Lymphoma)
04/01/2009 - "Burkitt lymphoma cell lines harbor large populations of FLAER(neg) cells, which are resistant to proaerolysin. "
04/01/2009 - "We identified a large GPI anchor protein deficient population in three different Burkitt lymphoma cell lines through proaerolysin treatment of the cells and flow cytometry analysis using a proaerolysin variant (FLAER). "
|2.||Prostate-Specific Antigen (Semenogelase)